# Study of Remodulin® in Pediatric Pulmonary Hypertension With Single Ventricular Physiology After Fontan Surgery

> **NCT02865733** · PHASE3 · COMPLETED · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 36 (actual)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DRUG:** Remodulin
- **DRUG:** distilled water

## Key facts

- **NCT ID:** NCT02865733
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-01
- **Primary completion:** 2018-12-31
- **Final completion:** 2019-08-20
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2020-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02865733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02865733, "Study of Remodulin® in Pediatric Pulmonary Hypertension With Single Ventricular Physiology After Fontan Surgery". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02865733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*